{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "0215468b-b1b3-4091-b22b-406a6f461679",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "19f4365e-d15d-425b-b3b5-5b669b277d1b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon powder formulation for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "e8a8e1cb-686b-4658-967a-58d55e36cd9d",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "d2244d76-5b0f-4f0f-a9c8-ef3db4ca2ff5",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular (IM) glucagon requiring reconstitution prior to administration.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human regular insulin",
        "type": {
          "id": "78ed8d91-e482-4340-a930-9c232a3fa966",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "fdb28337-8686-4b19-8751-e09d8de5d7df",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for controlled insulin-induced hypoglycemia procedure (0.3 U/mL).",
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Intravenous (IV) glucose",
        "type": {
          "id": "854c23b8-0075-451c-a012-d7d9b96465b6",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8276f00c-5ed2-4391-bf98-8132e3e9ea36",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if the patient experiences signs of severe hypoglycemia or insufficient response to glucagon."
      },
      {
        "id": "int_5",
        "name": "Acetaminophen",
        "type": {
          "id": "2954688f-f8f8-4079-a82e-79620c29fc9e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "75577ba9-f44c-4532-ae49-27208f44a3b1",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for treatment of headaches (1 g, max 2 g/24 hours)."
      },
      {
        "id": "int_6",
        "name": "Beta-blockers",
        "type": {
          "id": "64a4fe37-4061-45e4-8ea2-b5f8c60f4abd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "80425dae-2ff8-4cca-a212-5ec27f3d025a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_7",
        "name": "Indomethacin",
        "type": {
          "id": "98880d22-e10a-439c-9017-27dbdd3fc286",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b8338339-d275-4194-ab57-2356c41fceac",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_8",
        "name": "Warfarin",
        "type": {
          "id": "5bd267a5-f340-4821-b157-243a357617b2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b336acc0-faa2-4b5b-9298-47ed022af56f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_9",
        "name": "Anti-cholinergic drugs",
        "type": {
          "id": "a086188d-4bb6-4ada-845a-a2814433d286",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b0fa1519-37c2-43fe-8a37-c93d313ad5d9",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_10",
        "name": "Pro-motility medications",
        "type": {
          "id": "4b7237b8-e469-4ad6-90d5-80edcbd3a320",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "627e6b55-453e-4a72-ba13-bcceb03ad129",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Must be washed out 7 days before each period (e.g., metoclopramide, domperidone)."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "ec1da749-c34f-4676-a3bf-fac0b21e92d0",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "bc5980b8-ce2f-4bc4-988a-d4c556bdcc9f",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "b04e7ac4-7dda-44d2-bfdc-e80c785308ef",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Eli Lilly and Company"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "8a44de7d-768e-434a-a9ac-4353f45aec94",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "57094706-6513-44ef-86f3-304e76a1056f",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "b1620984-b410-49ea-864e-4065794c989b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018 Nasal Administration",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        },
        "duration": "Single administration per period"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen IM Injection",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration per period"
      },
      {
        "id": "admin_3",
        "name": "Insulin Infusion",
        "instanceType": "Administration",
        "dose": "2 to 4 mU/kg/min",
        "doseFrequency": "Continuous infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until plasma glucose reaches <60 mg/dL (max 4 hours)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Glucagon",
        "instanceType": "Substance",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "id": "sub_2",
        "name": "Human regular insulin",
        "instanceType": "Substance",
        "description": "Used for hypoglycemia induction."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal dosing device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Eli Lilly and Company"
      }
    ],
    "summary": {
      "interventionCount": 10,
      "productCount": 2,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon powder formulation for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular (IM) glucagon requiring reconstitution prior to administration."
      },
      {
        "name": "Human regular insulin",
        "role": "Background Therapy",
        "description": "Used for controlled insulin-induced hypoglycemia procedure (0.3 U/mL)."
      },
      {
        "name": "Intravenous (IV) glucose",
        "role": "Rescue Medication",
        "description": "Administered if the patient experiences signs of severe hypoglycemia or insufficient response to glucagon."
      },
      {
        "name": "Acetaminophen",
        "role": "Concomitant Medication",
        "description": "Permitted for treatment of headaches (1 g, max 2 g/24 hours)."
      },
      {
        "name": "Beta-blockers",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Indomethacin",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Warfarin",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Anti-cholinergic drugs",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Pro-motility medications",
        "role": "Concomitant Medication",
        "description": "Must be washed out 7 days before each period (e.g., metoclopramide, domperidone)."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Dry powder",
        "strength": "3 mg",
        "manufacturer": "Eli Lilly and Company"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Dry powder",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      }
    ],
    "substances": [
      {
        "name": "Glucagon",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "name": "Human regular insulin",
        "description": "Used for hypoglycemia induction."
      }
    ],
    "administrations": [
      {
        "name": "LY900018 Nasal Administration",
        "dose": "3 mg",
        "frequency": "Single dose",
        "route": "Nasal",
        "duration": "Single administration per period"
      },
      {
        "name": "GlucaGen IM Injection",
        "dose": "1 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Single administration per period"
      },
      {
        "name": "Insulin Infusion",
        "dose": "2 to 4 mU/kg/min",
        "frequency": "Continuous infusion",
        "route": "Intravenous",
        "duration": "Until plasma glucose reaches <60 mg/dL (max 4 hours)"
      }
    ],
    "devices": [
      {
        "name": "Nasal dosing device",
        "manufacturer": "Eli Lilly and Company",
        "purpose": "Single-use device to deliver 3 mg glucagon powder for absorption through the nasal mucosa."
      }
    ]
  }
}